{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:03:36Z","timestamp":1791349416109,"version":"4.3.1"},"reference-count":29,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,11,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>WHIM syndrome is a rare congenital immunodeficiency disorder characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (neutropenia because of impaired egress from the BM); most patients also have severe panleukopenia. Because WHIM syndrome is caused by mutations in the chemokine receptor CXCR4 that result in increased agonist-dependent signaling, we hypothesized that the CXCR4 antagonist plerixafor (Mozobil [Genyzme Corporation], AMD3100), might be an effective treatment. To test this, we enrolled 3 unrelated adult patients with the most common WHIM mutation, CXCR4R334X, in a phase 1 dose-escalation study. Plerixafor increased absolute lymphocyte, monocyte, and neutrophil counts in blood to normal without significant side effects in all 3 patients. Peak responses occurred at 3-12 hours after injection and waned by 24 hours after injection which tracked the drug's pharmacokinetics. All 3 cell types increased in a dose-dependent manner with the rank order of responsiveness absolute lymphocyte &gt; monocyte &gt; neutrophil. These data provide the first pharmacologic evidence that panleukopenia in WHIM syndrome is caused by CXCL12-CXCR4 signaling-dependent leukocyte sequestration, and support continued study of plerixafor as mechanism-based therapy in this disease. This study is registered at http:\/\/www.clinicaltrials.gov as NCT00967785.<\/jats:p>","DOI":"10.1182\/blood-2011-07-368084","type":"journal-article","created":{"date-parts":[[2011,9,3]],"date-time":"2011-09-03T20:44:04Z","timestamp":1315082644000},"page":"4957-4962","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":144,"title":["The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome"],"prefix":"10.1182","volume":"118","author":[{"given":"David H.","family":"McDermott","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ulrick","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Kwatemaa","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Anaya-O'Brien","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Penzak","sequence":"additional","affiliation":[{"name":"Pharmacy Department and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao Oliveira","family":"Filho","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A. Long","family":"Priel","sequence":"additional","affiliation":[{"name":"Clinical Services Program SAIC-Frederick Inc, NCI Frederick, Frederick, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corin","family":"Kelly","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Garofalo","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Littel","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M.","family":"Marquesen","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Hilligoss","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamma","family":"DeCastro","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Fleisher","sequence":"additional","affiliation":[{"name":"Division of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas B.","family":"Kuhns","sequence":"additional","affiliation":[{"name":"Clinical Services Program SAIC-Frederick Inc, NCI Frederick, Frederick, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Malech","sequence":"additional","affiliation":[{"name":"Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111808381903800_B1","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM196404022701402","article-title":"\u201cMyelokathexis\u201d\u2014a new form of chronic granulocytopenia. Report of a case.","volume":"270","author":"Zuelzer","year":"1964","journal-title":"N Engl J Med"},{"key":"2019111808381903800_B2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM196405072701902","article-title":"Chronic idiopathic granulocytopenia.","volume":"270","author":"Krill","year":"1964","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111808381903800_B3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0002-9343(90)90187-I","article-title":"A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia.","volume":"89","author":"Wetzler","year":"1990","journal-title":"Am J Med"},{"issue":"1","key":"2019111808381903800_B4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MOH.0b013e32831ac557","article-title":"WHIM syndrome: congenital immune deficiency disease.","volume":"16","author":"Kawai","year":"2009","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"2019111808381903800_B5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng1149","article-title":"Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease.","volume":"34","author":"Hernandez","year":"2003","journal-title":"Nat Genet"},{"issue":"10","key":"2019111808381903800_B6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1582-4934.2010.01210.x","article-title":"AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome","volume":"15","author":"McDermott","year":"2011","journal-title":"J Cell Mol Med"},{"issue":"6","key":"2019111808381903800_B7","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1182\/blood-2004-06-2289","article-title":"WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.","volume":"105","author":"Balabanian","year":"2005","journal-title":"Blood"},{"issue":"12","key":"2019111808381903800_B8","doi-asserted-by":"crossref","first-page":"e8102","DOI":"10.1371\/journal.pone.0008102","article-title":"Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor.","volume":"4","author":"McCormick","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"2019111808381903800_B9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2006-05-025296","article-title":"WHIM syndrome myelokathexis reproduced in the NOD\/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.","volume":"109","author":"Kawai","year":"2007","journal-title":"Blood"},{"issue":"15","key":"2019111808381903800_B10","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1182\/blood-2010-03-276972","article-title":"Live imaging of neutrophil motility in a zebrafish model of WHIM syndrome.","volume":"116","author":"Walters","year":"2010","journal-title":"Blood"},{"issue":"28","key":"2019111808381903800_B11","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1200\/JCO.2008.20.7209","article-title":"Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.","volume":"27","author":"DiPersio","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111808381903800_B12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/bmt.2009.119","article-title":"Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization.","volume":"45","author":"Dugan","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"2019111808381903800_B13","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.95.16.9448","article-title":"Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.","volume":"95","author":"Ma","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6685","key":"2019111808381903800_B14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/31261","article-title":"The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.","volume":"393","author":"Tachibana","year":"1998","journal-title":"Nature"},{"issue":"6685","key":"2019111808381903800_B15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"},{"issue":"2","key":"2019111808381903800_B16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1067\/mai.2003.58","article-title":"Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.","volume":"111","author":"Jirapongsananuruk","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"15","key":"2019111808381903800_B17","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2010-01-265942","article-title":"Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.","volume":"116","author":"McDermott","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111808381903800_B18","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1128\/AAC.44.6.1667-1673.2000","article-title":"Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.","volume":"44","author":"Hendrix","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2019111808381903800_B19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3816\/SCT.2004.n.008","article-title":"Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR4 antagonist.","volume":"1","author":"H\u00fcbel","year":"2004","journal-title":"Support Cancer Ther"},{"issue":"8","key":"2019111808381903800_B20","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2003-02-0663","article-title":"Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.","volume":"102","author":"Liles","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111808381903800_B21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(03)00263-2","article-title":"Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.","volume":"19","author":"Martin","year":"2003","journal-title":"Immunity"},{"issue":"4","key":"2019111808381903800_B22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-7613(00)80046-1","article-title":"The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment.","volume":"10","author":"Ma","year":"1999","journal-title":"Immunity"},{"issue":"2","key":"2019111808381903800_B23","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/01.qai.0000137371.80695.ef","article-title":"Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.","volume":"37","author":"Hendrix","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"2019111808381903800_B24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00005-008-0046-x","article-title":"Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome.","volume":"56","author":"Siedlar","year":"2008","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"2019111808381903800_B25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clim.2010.02.006","article-title":"Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.","volume":"135","author":"McGuire","year":"2010","journal-title":"Clin Immunol"},{"issue":"9","key":"2019111808381903800_B26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni1100","article-title":"Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.","volume":"5","author":"Allen","year":"2004","journal-title":"Nat Immunol"},{"issue":"5","key":"2019111808381903800_B27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.immuni.2009.03.015","article-title":"Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow.","volume":"30","author":"Tokoyoda","year":"2009","journal-title":"Immunity"},{"issue":"3","key":"2019111808381903800_B28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.4049\/jimmunol.174.3.1269","article-title":"Bone marrow is a preferred site for homeostatic proliferation of memory CD8 T cells.","volume":"174","author":"Becker","year":"2005","journal-title":"J Immunol"},{"issue":"12","key":"2019111808381903800_B29","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.4049\/jimmunol.1100243","article-title":"Human bone marrow hosts polyfunctional memory CD4+ and CD8+ T cells with close contact to IL-15\u2013producing cells.","volume":"186","author":"Herndler-Brandstetter","year":"2011","journal-title":"J Immunol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/18\/4957\/1463842\/zh804411004957.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/18\/4957\/1463842\/zh804411004957.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T09:05:15Z","timestamp":1574067915000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/18\/4957\/29342\/The-CXCR4-antagonist-plerixafor-corrects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,3]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2011,11,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-07-368084","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,3]]}}}